Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Consort Medical PLC

+ Add to Watchlist

CSRT:LN

881.500 GBp 4.500 0.51%

As of 11:35:26 ET on 02/27/2015.

Snapshot for Consort Medical PLC (CSRT)

Open: 893.500 Day's Range: 880.500 - 893.500 Volume: 16,716
Previous Close: 886.000 52wk Range: 650.000 - 914.035 1-Yr Rtn: -0.11%

Stock Chart for CSRT

No chart data available.
  • CSRT:LN 881.500
  • 1D
  • 1M
  • 1Y
886.000
Interactive CSRT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSRT

Current P/E Ratio (ttm) 20.0430
Estimated P/E(04/2015) 20.5478
Relative P/E vs. UKX 0.8857
Earnings Per Share (GBP) (ttm) 0.4398
Est. EPS (GBP) (04/2015) 0.4290
Est. PEG Ratio -
Market Cap (M GBP) 432.59
Shares Outstanding (M) 49.07
30 Day Average Volume 133,497
Price/Book (mrq) 2.2207
Price/Sale (ttm) 2.6438
Dividend Indicated Gross Yield 2.28%
Cash Dividend (GBp) 6.4300
Dividend Ex-Date 01/15/2015
5 Year Dividend Growth 1.62%
Next Earnings Announcement 06/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSRT

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for CSRT

Consort Medical PLC supplies drug delivery devices and development services to pharmaceutical companies. The Company develops and manufactures metered dose inhaler valves actuators, compliance-aids, dry powder devices, disposable face masks, breathing circuits and laryngeal tubes.

Jonathan GlennChief Executive OfficerRichard CottonFinance Director/Secretary
Lisa KingDirector:Human ResourcesIain WardSecretary/General Counsel
More Company Profile & Key Executives for CSRT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil